/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $6M · -486.21% margin · -$35M FCF
The business is unprofitable at the operating level (-469.30% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue growth slowed to 0.1%, essentially flat. This is a business that needs a catalyst.
Negative free cash flow of -$40M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$6M
Net Income (TTM)
-$30M
▲ +47.1% YoY
Op. Margin
-486.21%
▲ +480.6pp YoY
ROIC
-47.48%
▲ +10.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$35M
▲ +34.9% YoY
Op. Cash Flow (TTM)
-$35M
▲ +35.0% YoY
Net Debt
-$584K
Net Cash Position
Cash & Equiv.
$23M
5Y CAGR: +101.6%
Continue Research